Investigator Initiated Clinical Study to Explore the Efficacy and Safety of Human Placenta Hydrolysate in the Chronic Fatigue Patients

NCT01742013 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Chronic Fatigue Syndrome
Idiopathic Chronic Fatigue

Interventions

DRUG: GCJBP Laennec Inj.
DRUG: Placebo

Sponsor

Ho Cheol Shin, M.D., Ph.D.

Collaborators

[object Object]
[object Object]
[object Object]